GENINUS Inc.

A389030

KR7389030008

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
1,888 ^KRW	-1.20%		-1.15%	-28.21%

2021	GENINUS Inc. has completed an IPO in the amount of KRW 40 billion.	CI
2021	GENINUS Inc. has filed an IPO.	CI

GENINUS Inc. has filed an IPO.

July 08, 2021 at 05:00 am

GENINUS Inc. has filed an IPO.

Security Name: Shares
Security Type: Common Stock
PriceRange: KRW 24700 to KRW 32300

Transaction Features: Sponsor Backed Offering

Latest news about GENINUS Inc.

GENINUS Inc. has completed an IPO in the amount of KRW 40 billion.	01/11/21	CI
GENINUS Inc. has filed an IPO.	08/07/21	CI

Geninus Inc is a Korea-based company principally engaged in the bioinformatics analysis business. The Company is engaged in the provision of single cell analysis services, genetic testing for disease prediction for the public, cancer genome analysis solutions based on tissue biopsy and other services. It is also engaged personal genetic testing, software development, rental business and others.

Sector

Biotechnology & Medical Research

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
GENINUS INC.	-28.21%	45.51M
EXACT SCIENCES CORPORATION	-38.56%	8.39B
GUARDANT HEALTH, INC.	+0.18%	3.32B
IOVANCE BIOTHERAPEUTICS, INC.	+9.29%	2.49B
BGI GENOMICS CO., LTD.	-18.21%	2.06B
VERACYTE, INC.	-24.57%	1.59B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+32.37%	1.15B
SEEGENE, INC.	-7.64%	704M
CAREDX, INC	+8.42%	678M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-29.59%	508M